Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Recurrence 1Polycystic Ovary Syndrome 1Infertility, Female 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Ovulation Induction × Clear all
NCT07148141 2026-01-28

FERTICAN

University Hospital, Clermont-Ferrand

Active not recruiting
100 enrolled
Breast

Breast Neoplasms, Infertility, Female

NCT02656121 2018-11-16

PCOSD

Ain Shams University

Phase 2 Completed
300 enrolled

Polycystic Ovary Syndrome

NCT00504699 2018-03-29

Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients

New York Medical College

Phase NA Terminated
120 enrolled
Breast

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡